We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PFIZER SETTLES NEURONTIN OFF-LABEL MARKETING CASE
PFIZER SETTLES NEURONTIN OFF-LABEL MARKETING CASE
May 13, 2004
Pfizer has agreed to plead guilty to federal criminal charges, enter into a corporate integrity agreement (CIA) with the HHS Office of Inspector General and pay $430 million to settle allegations that its Warner-Lambert unit caused doctors to submit Medicaid claims for unapproved uses of one of its drugs.